Table 2. RF Values of the 12 Selected Compounds in the Resistant HT29/DOX and A549/DOX Cell Lines.
| HT29/DOX |
A549/DOX |
|||
|---|---|---|---|---|
| RFa | RFa | |||
| compounds | 1 μM | 3 μM | 1 μM | 3 μM |
| 1 | 14.9 | 18.7 | 21.5 | 30.2 |
| 2 | 38.4 | 44.5 | 54.0 | 64.3 |
| 4 | 21.7 | 41.1 | 39.5 | 65.0 |
| 5 | 44.4 | 85.7 | 70.4 | 155.0 |
| 10 | 40.2 | 47.5 | 65.1 | 85.4 |
| 11 | 10.8 | 29.7 | 17.6 | 49.8 |
| 13 | 14.1 | 4.15 | 16.5 | 11.6 |
| 14 | 46.2 | 63.2 | 67.4 | 103.0 |
| 19 | 60.5 | 87.0 | 92.2 | 131.6 |
| 20 | 13.1 | 16.2 | 19.2 | 31.5 |
| 22 | 37.6 | 61.9 | 61.9 | 82.4 |
| 23 | 27.2 | 26.6 | 37.0 | 41.3 |
Inhibition of the P-gp transport activity on two resistant cell lines, expressed as RF that is the ratio between the IC50 of doxorubicin alone and in the presence of modulators (RF = IC50 of doxorubicin – modulator/IC50 of doxorubicin + modulator).